dorsaVi Ltd (DVL) Earnings Call Transcripts
dorsaVi Ltd's Latest Earnings Call - May 20, 2026
In the earnings call for Q2 2026, dorsaVi Ltd (DVL:AU) highlighted significant advancements in their technology, particularly the development of their 22-nanometer RRAM chip in collaboration with NTU and ITRI. The company is transitioning from laboratory testing to commercial production, which management described as a 'milestone for the business.' While specific revenue and earnings figures were not disclosed, the focus on neuromorphic computing and local inference capabilities suggests potential for future revenue growth. Management maintained a positive outlook on the market demand for their technologies, particularly in AI and edge computing applications.
Reported metrics
| Metric | Value |
|---|---|
| Revenue | (null) |
| Earnings | (null) |
| R&D Investment | (null) |
| Production Timeline | 180 nanometers (positive) |
| Partnerships | 3 key partners (positive) |
| Market Size Potential | $217 billion (positive) |
Guidance from management
Management signaled a strong commitment to advancing their RRAM technology and integrating it into their existing sensor products, with a focus on commercial viability and market readiness.
What analysts pressed on
Analysts expressed concerns about the timeline for commercialization and the competitive landscape in the semiconductor industry. There were questions regarding the scalability of their technology and how it would compete against established players in the market.
Main topics on the call
- Technological Advancements — dorsaVi is advancing its technology with a focus on neuromorphic computing and RRAM chips. Management stated, 'we know that we can take it down to 22 nanometers,' indicating confidence in their development process.
- Strategic Partnerships — The company emphasized its strong partnerships with institutions like Technion and NTU, which are crucial for their RRAM development. Management noted, 'we have some of the best in the world partnering with us.'
- Market Positioning — dorsaVi is positioning itself to capitalize on the growing demand for localized decision-making in AI and edge computing. Management mentioned, 'the more and more you can do at the Ultra Edge, the more and more you free ...
- Commercialization Plans — Management outlined plans to commercialize their neuromorphic technology, stating, 'we will start with ourselves by putting some... of the neuromorphic capability onto our sensor.' This indicates a proactive approach to ...
Read the full dorsaVi Ltd transcript (May 20, 2026) → Summary generated from the call transcript; every figure above is stated by management on the record.
About dorsaVi Ltd
dorsaVi Ltd (DVL) is a publicly listed company in the Health Care Equipment and Supplies industry, within the Health Care sector. It trades on ASX and is based in AU. EarningsCalls.dev maintains a free, full-text archive of its earnings call transcripts — 3 calls on record spanning May 7, 2020 to May 20, 2026. Every transcript is split into speaker-by-speaker segments with headline metrics, free to read or available through our REST API.
Earnings Call History
EarningsCalls.dev has 3 dorsaVi Ltd earnings call transcripts on record, spanning May 7, 2020 to May 20, 2026. The most recent call on file is dated May 20, 2026. The full list is below — each row opens the complete, free-to-read transcript.
- Ticker
- DVL
- Exchange
- ASX
- Country
- AU
- Sector
- Health Care
- Calls on record
- 3
- First call
- May 7, 2020
- Most recent
- May 20, 2026
| Quarter | Date | |
|---|---|---|
| Special Calls | May 20, 2026 | Read transcript → |
| Special Calls | Sep 1, 2025 | Read transcript → |
| Q3 FY2020 | May 7, 2020 | Read transcript → |